Michael G. Rosenblum
Immunopharmacology and Targeted Therapy Section
Department of Bioimmunotherapy
University of Texas M.D. Anderson Cancer Center
Houston
USA
Name/email consistency: high
- Design, expression, purification, and characterization, in vitro and in vivo, of an antimelanoma single-chain Fv antibody fused to the toxin gelonin. Rosenblum, M.G., Cheung, L.H., Liu, Y., Marks, J.W. Cancer Res. (2003)
- A novel recombinant fusion toxin targeting HER-2/NEU-over-expressing cells and containing human tumor necrosis factor. Rosenblum, M.G., Horn, S.A., Cheung, L.H. Int. J. Cancer (2000)